Samsung Biologics (207940 KS/Buy)Spin-Off Likely to Unlock Additional Value
We raise our target price for Samsung Biologics to W1,600,000 (from W1,400,000), which is based on the sum of the values of the CDMO business...
591 Views
[2H26 Outlook] Pharma/BiotechCatalysts for a biotech rebound
Biotech stocks performed well early this year, driven by optimism surrounding the government's KOSDAQ 3,000 target and supportive fund flows...
119 Views
Mirae Asset Minutes [2026: Volume 2]Biweekly Strategy Meeting Recap
Driven by surging power demand from data centers, new capacity additions are accelerating across large-scale nuclear power plants, SMRs, and gas...
172 Views
Mirae Asset Minutes [2026: Volume 1]Biweekly strategy meeting recap
Hyundai Motor Group (HMG) is set to announce its AI robotics strategy on Jan. 6 and is expected to appoint an advanced vehicle platform division...
182 Views
Mirae Asset Minutes [2025: Volume 23]Biweekly strategy meeting recap
While rising memory prices could modestly weigh on global IT device sales in 2026, we note that memory chips’ share of smartphone BoM costs is only...
261 Views